October 3, 2022
Pharma Services
Evolution, innovation, and disruption across healthcare is common - and the momentum within outsourced pharma services continues to fuel market attention and activity. The on-going shift to specialty medicine and precision medicine, and the macro forces advancing patient-centricity, evidence-based practices, and value-based initiatives has created the backdrop for robust interest, investment, and innovation in the pharma services landscape.
The seven pharma services sub-sectors outlined in this report demonstrate this momentum and highlight the future opportunity:
- Decentralized Clinical Trials (DCT)
- Real-World Data, Evidence, Research, and Data Interoperability
- Medical Affairs and Communication (MAC)
- Market Access
- Patient Services
- HUB Services
- Tech-Enabled Commercialization Services
